Harbinger Health

Harbinger Health develops solutions for cancer detection.

Health and bio Data and analytics

Latest funding

$140M Series B+ · September 28, 2023

Led by Flagship Pioneering · Source: fundraisingfox.com

All 2 rounds ↓

Website: harbinger-health.com.

X: @HarbingerHlth · 193 followers.

LinkedIn: harbinger-health.

Categories: Health and bio Data and analytics.

Sectors: Artificial Intelligence (AI), Biotechnology, Health Care, Health Diagnostics.

Stage: Series B+.

Based in: Cambridge, United States.

Last round: Apr 14, 2026 · 215 days ago.

Headcount: 51–100 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@HarbingerHlth · created Dec 5, 2021 (4 years old) · 193 followers

Website registeredNov 18, 2021 (5 years old)

About Harbinger Health

Its RESOLVE™ solutions aim to resolve uncertainty between suspicion of cancer and diagnosis. The company uses a platform called Harbinger HX™ that integrates biology, technology, data, and analytics. Harbinger Health partners with organizations like Dana-Farber Cancer Institute and HCA Healthcare.

TIMELINE · MONEY RAISED

Harbinger Health | 679 days from website to first raise on record

@HarbingerHlth·Raised $140M in 1 sourced round·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Apr 14, 2026	Round	undisclosed	—	fundraisingfox.com
Sep 28, 2023	Series B+	$140M	FFlagship Pioneering	fundraisingfox.com

Timeline

December 5, 2021
X account created
November 18, 2021
Website created

Founders and team

FM
Franziska Michor Chief Scientific Advisor & Co-Founder

source: harbinger-health.com
AP
Anthony P. Shuber Chief Innovation Officer
DH
Dymeka Harrison Chief Commercial Officer
GA
Gisela A. Paulsen Chief Operating Officer
MS
Mathew Sargent Chief Business Officer

Investors

Companies like Harbinger Health

PPrima MenteSeed · Apr 2026
DDxcover$6.2M Series A · Feb 2025
VViz.ai$100M Series B+ · Apr 2022
OOncoliqSeed · Jul 2026
HHarae Dx
FFreehand$75M Series B+ · Jul 2026

Other companies backed by Flagship Pioneering

AAmpersand Biomedicines$65M Series B+ · Mar 2025
AApriori Bio$1.1M · Jul 2024
PPrologue Medicines$50M · May 2024
QQuotient Therapeutics$50M Series B+ · Nov 2023
CCellaritySeries B+ · Nov 2024

Flagship Pioneering portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/harbinger-health (get a free API key).